Literature DB >> 17198808

Impact of left atrial appendage exclusion on left atrial function.

Keiji Kamohara1, Zoran B Popović, Masao Daimon, Maureen Martin, Yoshio Ootaki, Masatoshi Akiyama, Firas Zahr, Faruk Cingoz, Chiyo Ootaki, Michael W Kopcak, Raymond Dessoffy, Jenny Liu, James D Thomas, A Marc Gillinov, Kiyotaka Fukamachi.   

Abstract

OBJECTIVES: We sought to investigate the short-term and midterm effects of left atrial appendage exclusion on left atrial function. Left atrial appendage exclusion is considered a possible therapeutic option for stroke prevention in patients with atrial fibrillation. Favorable outcomes have encouraged widespread use of left atrial appendage exclusion for cardiac surgical patients-even for patients in sinus rhythm who have stroke risk factors; however, the chronic effects on left atrial function of left atrial appendage exclusion are unclear.
METHODS: Nineteen mongrel dogs (29.7 +/- 5.2 kg) in sinus rhythm were studied. The Doppler signals from the pulmonary venous flow, transmitral flow, and tissue Doppler imaging of mitral annular motion were obtained before and after left atrial appendage exclusion. Dogs were evaluated in the same manner at 7 days (n = 2), 30 days (n = 7), or 90 days (n = 10) after left atrial appendage exclusion.
RESULTS: Except for a significant increase in early diastolic transmitral flow velocity after left atrial appendage exclusion (P = .01), no significant differences were found in any parameters related to the transmitral flow and tissue Doppler imaging measurements throughout follow-up. The systolic components of pulmonary venous flow at follow-up revealed a significant reduction relative to baseline (peak systolic velocity P < .0001, systolic velocity-time integral P < .0001), despite the lack of significant changes in left atrial pressure, left ventricular volume, and stroke volume.
CONCLUSION: Left atrial appendage exclusion may affect left atrial reservoir function in the short-term and midterm periods. Further long-term studies with more clinically relevant models are needed.

Entities:  

Mesh:

Year:  2007        PMID: 17198808     DOI: 10.1016/j.jtcvs.2006.08.057

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device.

Authors:  Ryan Maybrook; Jayasree Pillarisetti; Vivek Yarlagadda; Sampath Gunda; Arun Raghav Mahankali Sridhar; Brent Deibert; Muhammad R Afzal; Madhu Reddy; Donita Atkins; Matthew Earnest; Ryan Ferrell; Jayant Nath; Arun Kanmanthareddy; Sudharani Bommana; Rajasingh Johnson; Sandeep Reddy Koripalli; Buddhadeb Dawn; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2015-05-09       Impact factor: 1.900

Review 2.  Left atrial appendage exclusion for atrial fibrillation.

Authors:  Faisal F Syed; Christopher V DeSimone; Paul A Friedman; Samuel J Asirvatham
Journal:  Cardiol Clin       Date:  2014-10-23       Impact factor: 2.213

3.  Improvement in Left Atrial Strain among Patients Undergoing Percutaneous Left Atrial Appendage Closure.

Authors:  Shun Ijuin; Ali Hamadanchi; Franz Haertel; Laura Baez; Paul Christian Schulze; Marcus Franz; Sven Moebius-Winkler
Journal:  J Cardiovasc Echogr       Date:  2020-04-13

4.  Hemodynamic impact of percutaneous left atrial appendage closure in patients with paroxysmal atrial fibrillation.

Authors:  Lluis Asmarats; Mathieu Bernier; Gilles O'Hara; Jean-Michel Paradis; Kim O'Connor; Jonathan Beaudoin; Sylvie Bilodeau; Rafael Cavalcanti; Jean Champagne; Josep Rodés-Cabau
Journal:  J Interv Card Electrophysiol       Date:  2018-06-04       Impact factor: 1.900

5.  Minimally invasive surgical therapies for atrial fibrillation.

Authors:  Yoshitsugu Nakamura; Bob Kiaii; Michael W A Chu
Journal:  ISRN Cardiol       Date:  2012-05-16

Review 6.  Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.

Authors:  Laura Ueberham; Nikolaos Dagres; Tatjana S Potpara; Andreas Bollmann; Gerhard Hindricks
Journal:  Adv Ther       Date:  2017-09-27       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.